Bone building with bortezomib

Por Roodman, G. David
Publicado em 2008

Deciphering Cancer and Bone Interactions for Therapeutic Benefits

Por Roodman, G David
Publicado no JBMR Plus (2019)

Myeloma bone disease: Pathophysiology and management

Por Silbermann, Rebecca, Roodman, G. David
Publicado no J Bone Oncol (2013)

Multiple Myeloma and Bone: The Fatal Interaction

Por Marino, Silvia, Roodman, G. David
Publicado no Cold Spring Harb Perspect Med (2018)

Paget disease of bone

Por Roodman, G. David, Windle, Jolene J.
Publicado em 2005

Pathobiology of Paget's Disease of Bone

Por Galson, Deborah L., Roodman, G. David
Publicado em 2014

Chemokines in multiple myeloma

Por Aggarwal, Rohit, Ghobrial, Irene M., Roodman, G. David
Publicado em 2006

Mechanisms of multiple myeloma bone disease

Por Galson, Deborah L, Silbermann, Rebecca, Roodman, G David
Publicado em 2012

Role of osteocytes in multiple myeloma bone disease

Por Delgado-Calle, Jesus, Bellido, Teresita, Roodman, G. David
Publicado no Curr Opin Support Palliat Care (2014)

Osteoblast suppression in multiple myeloma bone disease

Por Adamik, Juraj, Galson, Deborah L, Roodman, G David
Publicado no J Bone Oncol (2018)

Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease

Por Adamik, Juraj, Roodman, G David, Galson, Deborah L
Publicado no JBMR Plus (2019)

Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses the pro-survival XBP1 signaling in human multiple myeloma cells

Por Wang, Feng-Ming, Galson, Deborah L., Roodman, G. David, Ouyang, Hongjiao
Publicado em 2011

Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype

Por Kurihara, Noriyoshi, Reddy, Sakamuri V., Menaa, Cheikh, Anderson, Dirk, Roodman, G. David
Publicado em 2000

A novel role of IL-17–producing lymphocytes in mediating lytic bone disease in multiple myeloma

Por Noonan, Kimberly, Marchionni, Luigi, Anderson, Judy, Pardoll, Drew, Roodman, G. David, Borrello, Ivan
Publicado em 2010

Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation

Por Xu, Guoshuang, Liu, Kai, Anderson, Judy, Patrene, Kenneth, Lentzsch, Suzanne, Roodman, G. David, Ouyang, Hongjiao
Publicado em 2012

Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease

Por Choi, Sun Jin, Oba, Yasuo, Gazitt, Yair, Alsina, Melissa, Cruz, Jose, Anderson, Judith, Roodman, G. David
Publicado em 2001

Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures

Por Menaa, Cheikh, Devlin, Rowena D., Reddy, Sakamuri V., Gazitt, Yair, Choi, Sun Jin, Roodman, G. David
Publicado em 1999

Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation

Por Hiruma, Yuko, Honjo, Tadashi, Jelinek, Diane F., Windle, Jolene J., Shin, Jaekyoon, Roodman, G. David, Kurihara, Noriyoshi
Publicado em 2009

Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment

Por D'Souza, Sonia, Kurihara, Noriyoshi, Shiozawa, Yusuke, Joseph, Jeena, Taichman, Russell, Galson, Deborah L., Roodman, G. David
Publicado em 2012

The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors

Por Lipton, Allan, Uzzo, Robert, Amato, Robert J., Ellis, Georgiana K., Hakimian, Behrooz, Roodman, G. David, Smith, Matthew R.
Publicado em 2009